Zhong-Zhu Chen

Zhong-Zhu Chen

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CXChuan Xu
Chuan Xu
GJGuoxiang Jin
Guoxiang Jin
HWHong Wu
Hong Wu
WCWei Cui
Wei Cui
YWYu-Hui Wang
Yu-Hui Wang
HLHui-Kuan Lin
Hui-Kuan Lin
Cancer stem-like cells (CSLCs) acquire enhanced immune checkpoint responses to evade immune cell killing and promote tumor progression. Here we showed that signal regulatory protein γ (SIRPγ) determined CSLC properties and immune evasiveness in a small population of lung adenocarcinoma (LUAD) cancer cells. A SIRPγhi population displayed CSLC properties and transmitted the immune escape signal through sustaining CD47 expression in both SIRPγhi and SIRPγlo/– tumor cells. SIRPγ bridged MST1 and PP2A to facilitate MST1 dephosphorylation, resulting in Hippo/YAP activation and leading to cytokine release by CSLCs, which stimulated CD47 expression in LUAD cells and consequently inhibited tumor cell phagocytosis. SIRPγ promoted tumor growth and metastasis in vivo through YAP signaling. Notably, SIRPγ targeting with genetic SIRPγ knockdown or a SIRPγ-neutralizing antibody inhibited CSLC phenotypes and elicited phagocytosis that suppressed tumor growth in vivo. SIRPG was upregulated in human LUAD and its overexpression predicted poor survival outcome. Thus, SIRPγhi cells serve as CSLCs and tumor immune checkpoint–initiating cells, propagating the immune escape signal to the entire cancer cell population. Our study identifies Hippo/YAP signaling as the first mechanism by which SIRPγ is engaged and reveals that targeting SIRPγ represents an immune- and CSLC-targeting strategy for lung cancer therapy.

1 September 2021 in Molecular Cell
Verified
Journal Article
Closed access
CHChe-Chia Hsu
Che-Chia Hsu
XZXian Zhang
Xian Zhang
GWGuihua Wang
Guihua Wang
WZWeina Zhang
Weina Zhang
ZCZhen Cai
Zhen Cai
HLHui-Kuan Lin
Hui-Kuan Lin

20 August 2019 in Organic Letters
Verified
Journal Article
Closed access
CQChuan-Hua Qu
Chuan-Hua Qu
GSGui-Ting Song
Gui-Ting Song
JXJia Xu
Jia Xu
WYWei Yan
Wei Yan
CZChenghe Zhou
Chenghe Zhou
ZXZhi-Gang Xu
Zhi-Gang Xu

16 January 2018 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
JLJie Lei
Jie Lei
JMJiang-Ping Meng
Jiang-Ping Meng
DTDian-Yong Tang
Dian-Yong Tang
BFBrendan Frett
Brendan Frett
ZCZhong-Zhu Chen
Zhong-Zhu Chen
ZXZhi-Gang Xu
Zhi-Gang Xu

25 May 2020 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
JLJie Lei
Jie Lei
YLYong Li
Yong Li
JXJia Xu
Jia Xu
DTDian-Yong Tang
Dian-Yong Tang
JSJing-Wei Shao
Jing-Wei Shao
ZXZhi-Gang Xu
Zhi-Gang Xu
A green 1,4-addition isocyanide-based three-component reaction was developed to synthesize chromanones via a facile, mild, and efficient one-pot protocol without a metal catalyst. The 1,4-addition of isocyanides occurred at the C-2 position of chromones instead of the Schiff base in neat water. We found that the hydrogen bond can dictate the stereo-outcome of olefins, providing an effective method for the diastereomer-selective synthesis of this type of chromanone. The novel green synthetic protocol allowed the quick synthesis of complex chromanones in an environmentally friendly manner.

3 May 2021 in Chinese Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
CQChuan‐Hua Qu
Chuan‐Hua Qu
GSGui‐Ting Song
Gui‐Ting Song
JOJian‐Hua Ou
Jian‐Hua Ou
DTDian‐Yong Tang
Dian‐Yong Tang
ZXZhi-Gang Xu
Zhi-Gang Xu
ZCZhong-Zhu Chen
Zhong-Zhu Chen